SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

JUBILANT PHARMOVA

BSE: 530019 02 Oct 2025
Healthcare
₹ 1113.5
JUBILANT PHARMOVA LIMITED specializes in Pharmaceuticals within the Healthcare sector.

JUBILANT PHARMOVA - Share Price & Details

Market Cap
₹16,613
High /Low
1,310 / 802.0
Stock P/E
34.2
Book Value
₹393.0
Dividend Yield
0.48
ROCE
9.54
ROE
₹9.55
Face Value
1.0
PEG Ratio
3.33
EVEBITDA
₹14.4
Debt
2,731
CMP / FCF
-551.0
Debt to equity
₹0.44
NP Ann
836
High price all time
1,310
Piotroski score
₹8.0
Graham Number
505.0
No. Eq. Shares
15.9
Net CF
₹132
Net profit
457
Price to book value
2.66
Interest Coverage
₹4.08
Low price all time
58.0
Industry PE
33.0
Reserves
₹6,239
Free Cash Flow
₹-38.5

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
530019602.058.0595.00.2616,61334.2
Concord Biotech Limited2176.65425.652039.884.071637746.0
CAPLIN POINT LABORATORIES LTD.2146.0858.91825.711.261548327.4

Peer Comparison Chart


About JUBILANT PHARMOVA

JUBILANT PHARMOVA LIMITED, with Security Code 530019, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Is Jubilant Pharmova Limited One of the Top Picks for Growth Investors in YEAR - Price Volatility Patterns & Affordable Investment Strategies

(28 Sep 2025)
Is Jubilant Pharmova Limited One of the Top Picks for Growth Investors in YEAR ✌️【Equity Trends】✌️ Our expert-picked stocks have delivered...
Read more →

What Technical Volume Patterns Indicate for Jubilant Pharmova Limited - Market Sentiment Surveys & Double Or Triple Investment

(28 Sep 2025)
【Investor Sentiment】✌️ Grow smarter with free access to high-growth picks and expert forecasts that often exceed 200% ROI.
Read more →

Jubilant Pharmova names Arun Kumar Sharma as interim CFO

(23 Sep 2025)
Noida: Jubilant Pharmova has announced the appointment of Arun Kumar Sharma as a Chief Financial Officer (CFO) and Key Managerial Personnel...
Read more →

Jubilant Pharmova appoints Arun Kumar Sharma as CFO

(23 Sep 2025)
Jubilant Pharmova's board approved the appointment of Arun Kumar Sharma as a chief financial officer (CFO) with effect from 1st October...
Read more →

Jubilant Pharma arm completes USFDA inspection with zero observations

(22 Sep 2025)
Noida: Jubilant Pharmova Limited has announced the completion of the United States Food and Drug Administration (USFDA) Post-marketing...
Read more →

Jubilant Pharmova's step-down subsidiary completes US FDA audit with no observations

(22 Sep 2025)
Jubilant Cadista is a subsidiary of Jubilant Pharma, which is the wholly owned subsidiary Jubilant Pharmova.
Read more →